Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease PDF Download

Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease PDF full book. Access full book title Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease by A. Michael Lincoff. Download full books in PDF and EPUB format.

Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease

Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease PDF Author: A. Michael Lincoff
Publisher: Springer Science & Business Media
ISBN: 1592597246
Category : Medical
Languages : en
Pages : 415

Book Description
In Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease, the major investigators working in this rapidly advancing field join together under the aegis of A. Michael Lincoff and Eric J. Topol to provide the first comprehensive overview of the preclinical and clinical development of the glycoprotein IIb/IIIa receptor antagonists. These acknowledged experts elucidate the theoretical basis for the inhibition of platelet aggregation in the treatment of coronary syndromes, present and synthesize evidence for the efficacy of glycoprotein IIb/IIIa blockade in inhibiting ischemic complications of both coronary intervention and acute coronary syndromes, and provide guidelines for the use of this novel class of agents in the clinical management of cardiovascular disease. They also compare the pharmacology and clinical efficacy of the currently available glycoprotein IIb/IIIa receptor inhibitors and speculate about further potential applications of these agents in the treatment of vascular disease. Written by the scientists and physicians who discovered and characterized this important new class of receptors, invented the first IIb/IIIa agents, and conducted the definitive clinical trials, Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease offers the most complete and authoritative review of these powerful new therapeutics available today.

Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease

Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease PDF Author: A. Michael Lincoff
Publisher: Springer Science & Business Media
ISBN: 1592597246
Category : Medical
Languages : en
Pages : 415

Book Description
In Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease, the major investigators working in this rapidly advancing field join together under the aegis of A. Michael Lincoff and Eric J. Topol to provide the first comprehensive overview of the preclinical and clinical development of the glycoprotein IIb/IIIa receptor antagonists. These acknowledged experts elucidate the theoretical basis for the inhibition of platelet aggregation in the treatment of coronary syndromes, present and synthesize evidence for the efficacy of glycoprotein IIb/IIIa blockade in inhibiting ischemic complications of both coronary intervention and acute coronary syndromes, and provide guidelines for the use of this novel class of agents in the clinical management of cardiovascular disease. They also compare the pharmacology and clinical efficacy of the currently available glycoprotein IIb/IIIa receptor inhibitors and speculate about further potential applications of these agents in the treatment of vascular disease. Written by the scientists and physicians who discovered and characterized this important new class of receptors, invented the first IIb/IIIa agents, and conducted the definitive clinical trials, Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease offers the most complete and authoritative review of these powerful new therapeutics available today.

Platelet Glycoprotein IIb/IIIa Receptor Blockers in Coronary Artery Disease

Platelet Glycoprotein IIb/IIIa Receptor Blockers in Coronary Artery Disease PDF Author: A Tevfik Gürmen
Publisher:
ISBN: 9789163117961
Category :
Languages : en
Pages : 122

Book Description


Platelet Glycoprotein IIb/IIIa Receptor Inhibitors in Cardiovascular Disease

Platelet Glycoprotein IIb/IIIa Receptor Inhibitors in Cardiovascular Disease PDF Author: A. Michael Lincoff
Publisher:
ISBN:
Category : Blood platelets
Languages : en
Pages : 476

Book Description
A. Michael Lincoff takes advantage of critically important new knowledge arising from recent clinical trials to update and expand his acclaimed Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease. This substantially enhanced Second Edition contains new chapters on the role of GPIIb/IIIa blockade during acute coronary syndromes, on outcomes with chronic oral GPIIb/IIIa blockade following acute coronary syndromes, and on fibrinolytic therapy during acute myocardial infarctions. Additional enhancements include revised findings from the latest trials of GPIIb/IIIa inhibition during percutaneous coronary intervention, discussion of GPIIb/IIIa blockade with other platelet and thrombin inhibitors, and a review of the potential effects beyond inhibition of platelet aggregation. The book also explains the scientific basis of this therapy, evaluates its benefits and risks for patients, and summarizes detailed data from its various clinical trials. Comprehensive and definitive, Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease, Second Edition offers physicians, cardiologists, emergency room doctors, and basic scientists a complete and authoritative review of the state-of-the-art in glycoprotein IIb/IIIa receptor inhibitor use today.

Antiplatelet Therapy In Ischemic Heart Disease

Antiplatelet Therapy In Ischemic Heart Disease PDF Author: Stephen D. Wiviott
Publisher: John Wiley & Sons
ISBN: 1444303341
Category : Medical
Languages : en
Pages : 312

Book Description
* Draws from expertise of leaders in antiplatelet therapy * Easy-to-use layout enables rapid browsing * Edited by a member of the prestigious TIMI study group withlong-standing experience in the field

Antiplatelet Therapy in Cardiovascular Disease

Antiplatelet Therapy in Cardiovascular Disease PDF Author: Ron Waksman
Publisher: John Wiley & Sons
ISBN: 1118494024
Category : Medical
Languages : en
Pages : 363

Book Description
Edited by a team of the world’s leading interventional cardiologists and educators, this new book is created with an eye to giving the reader a solid, practical, and clinically focused understanding of this important class of drugs, from basic science to a clear-headed discussion of complex topics such as combination therapies, drug-to-drug interactions, and resistance to antiplatelet agents. This important new book: Begins with a concise but thorough discussion of platelet biology and pathophysiology so that readers understand how antiplatelet agents work and why they produce such a varied range of complications, from minor GI upset to potentially life-threatening conditions such as neutropenia, a critical shortage of white blood cells. Thoroughly covers platelet function testing, including novel techniques. Clarifies current best practice regarding the use of antiplatelet agents in both chronic and acute cardiovascular disease. Reviews all types of antiplatelet agents – from aspirin to recently approved drugs – including indications, clinical outcomes, and side effects. Written by an international “who’s who” of experts in the field, Antiplatelet Therapy in Cardiovascular Disease also includes an entire section covering the use of antiplatelet drugs in PCIs, including percutaneous valve repair, which makes this text particularly essential to interventional cardiologists.

Glycoprotein IIb/IIIa Antagonists

Glycoprotein IIb/IIIa Antagonists PDF Author: S. Banerjee
Publisher:
ISBN: 9781894978545
Category : Blood platelets
Languages : en
Pages : 72

Book Description


The Use of Platelet Glycoprotein IIB/IIIA Receptor Antagonists in the Management of Unstable Angina and Non-st-elevation Myocardial Infarction

The Use of Platelet Glycoprotein IIB/IIIA Receptor Antagonists in the Management of Unstable Angina and Non-st-elevation Myocardial Infarction PDF Author: Chantal Pharand
Publisher:
ISBN:
Category : Angina pectoris
Languages : en
Pages : 31

Book Description


Economic Evaluation of Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention with Stenting

Economic Evaluation of Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention with Stenting PDF Author:
Publisher:
ISBN: 9781894978620
Category : Platelet glycoprotein GPIIb-IIIa complex
Languages : en
Pages : 78

Book Description


Glycoprotein IIb/IIIa Receptor Blockers in Acute Coronary Syndromes

Glycoprotein IIb/IIIa Receptor Blockers in Acute Coronary Syndromes PDF Author: Kristiaan Martijn Akkerhuis
Publisher:
ISBN: 9789073235908
Category :
Languages : en
Pages : 311

Book Description


Primary Angioplasty

Primary Angioplasty PDF Author: Timothy J Watson
Publisher: Springer
ISBN: 9811311145
Category : Medical
Languages : en
Pages : 338

Book Description
This book is open access under a CC BY 4.0 license. This quick-reference handbook offers a concise and practical review of key aspects of the treatment of ST-segment elevation myocardial infarction (STEMI) in the era of primary percutaneous coronary intervention (PPCI). In the context of STEMI, PPCI is the preferred mode of emergency revascularization. Access to PPCI is rapidly increasing and is now routinely practiced in both general and specialist hospitals and there has been a recent emphasis on developing STEMI networks to enhance and expedite the referral pathway. This coupled with concurrent developments to enhance the safety and efficacy of the PPCI procedure has heralded an era where STEMI interventions are increasingly considered an important subspecialty within interventional cardiology. Written by leading cardiologists who have been instrumental in the adoption of PPCI in their respective institutions, the book provides junior and senior cardiologists alike with insightful and thought-provoking tips and tricks to enhance the success of PPCI procedures, which may in turn translate into direct improvements in outcomes. The book is also relevant for healthcare providers and emergency department physicians.